By identifying the predominant population affected by GAPBP1-targeted therapy and determining the prognosis of lung cancer patients, we hope to find additional evidence to support the clinical application of GABPB1 in the diagnosis and treatment of lung cancer. Here, GABPB1 is linked to lung cancer.